Clinical Trial

The DC Cohort Longitudinal HIV Status Neutral Study

Study acronym: DC Cohort
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2010-09-21; most recent amendment 2026-01-29.
Status change: Not Yet Recruiting → Recruiting 2011-01-12
Trial Details
NCT Number NCT01206920
Lead Sponsor George Washington University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV, AIDS
Enrollment 19,000 participants
Start Date 2011-01
Primary Completion 2041-01 (estimated)
Study Completion 2041-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-02